News
/ Ayeza Ali - 3 years ago
Russia did not make decisions on the COVID-19 vaccination similar to the one made in France but decisions like that are being implemented on the regional level, Kremlin spokesman Dmitry Peskov said
News
/ Hafsa Jamal - 3 years ago
The Russian Direct Investment Fund (RDIF) expects the World Health Organization (WHO) to approve the Sputnik V COVID-19 vaccine in the fall, RDIF CEO Kirill Dmitriev said on Tuesday
News
/ Kainat Bashir - 3 years ago
More than 28.6 million Russians received vaccines against COVID-19, the deputy head of Russian health watchdog, Elena Ezhlova, said on Tuesday
News
/ Rehan Amjad - 3 years ago
More than half of Canada's residents aged over 12 years have received the required two COVID-19 vaccine shots, the Canadian CTV News broadcaster reported, citing the country's health ministry data
News
/ Anas Khan - 3 years ago
The Russian Direct Investment Fund (RDIF) and the Serum Institue of India (SII) will start production of the Sputnik V COVID-19 vaccine in September, according to a joint statement published on Tuesday
News
/ Rehan Amjad - 3 years ago
Iran started the domestic manufacturing of Russia's Sputnik V vaccine against COVID-19 and has already produced the first test batch, the Russian Direct Investment Fund (RDIF) said on Saturday
News
/ Imran Iqbal - 3 years ago
The new Delta coronavirus strain, which originated in India, is unmatched among other variants in terms of contagiousness as it develops inside a human body in a matter of days, Moscow Mayor Sergey Sobyanin said
News
/ Test Dummy Writer - 3 years ago
The Sputnik Light single-component vaccine against COVID-19 started to be introduced into domestic public use, Russian Health Minister Mikhail Murashko said on Saturday
News
/ Kamran Farid - 3 years ago
Russia recorded 21,665 COVID-19 cases in the past 24 hours, up from 20,393 the day before, while the total number reached 5,430,753, the federal response center said on Saturday
News
/ Nasir Mahmood - 3 years ago
Australian scientists have started the first phase of clinical trials of a new gene-based coronavirus vaccine, which is administered using a device without a needle, the University of Sydney announced on Friday